Soon after Dr. Sean Conley, the White House (WH) physician, said that President Donald Trump is "doing very well," a few of the WH reporters are contradicting Conley’s assessment.
Trump is not yet on a clear path to recovery from COVID-19 and some of his vital signs over the last 24 hours were very concerning, the WH press pool reported, citing a source familiar with the president’s health.
A CBS News reporter tweeted out,
BREAKING: White House press pool was just told: “The president’s vitals over the last 24hrs were very concerning and the next 48hrs will be critical in terms of his care. We’re still not on a clear path to a full recovery”— David Begnaud (@DavidBegnaud) October 3, 2020
•That’s a bleaker picture than Trumps Dr. just painted•
Begnaud noted: “Trump began exhibiting 'clinical indications' of COVID-19 on Thursday afternoon, earlier than known," citing WH doctor.
Meanwhile, BNO News seems to validate the story, noting, “it suggests the quote is coming from a senior White House official. It's not a typical 'anonymous sources' story.”
The White House, however, has not released any official statement confirming the above reports.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.